KD Logo

Investing in Mirum Pharmaceuticals Inc (MIRM) Is Getting More Attractive

Mirum Pharmaceuticals Inc’s recently made public that its CHIEF SCIENTIFIC OFFICER Vig Pamela unloaded Company’s shares for reported $1.04 million on Jun 24 ’24. In the deal valued at $34.00 per share,30,559 shares were sold. As a result of this transaction, Vig Pamela now holds 27,406 shares worth roughly $0.92 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Ramasastry Saira sold 5,000 shares, generating $128,400 in total proceeds. Upon selling the shares at $25.68, the Director now owns 0 shares.

Before that, BJERKHOLT ERIC bought 2,000 shares. Mirum Pharmaceuticals Inc shares valued at $49,600 were divested by the CHIEF FINANCIAL OFFICER at a price of $24.80 per share. As a result of the transaction, BJERKHOLT ERIC now holds 14,000 shares, worth roughly $0.47 million.

Stifel initiated its Mirum Pharmaceuticals Inc [MIRM] rating to a Buy in a research note published on April 17, 2024; the price target was $48. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in mid December has reiterated a ‘”a Buy”‘ rating for it. Morgan Stanley started covering the stock on November 13, 2023. It rated MIRM as “an Overweight”.

Price Performance Review of MIRM

On Tuesday, Mirum Pharmaceuticals Inc [NASDAQ:MIRM] saw its stock fall -1.41% to $33.68. Over the last five days, the stock has gained 1.63%. Mirum Pharmaceuticals Inc shares have risen nearly 14.09% since the year began. Nevertheless, the stocks have risen 30.19% over the past one year. While a 52-week high of $35.56 was reached on 07/01/24, a 52-week low of $23.14 was recorded on 04/25/24. SMA at 50 days reached $26.90, while 200 days put it at $28.24. A total of 0.38 million shares were traded, compared to the trading of 0.69 million shares in the previous session.

Levels Of Support And Resistance For MIRM Stock

The 24-hour chart illustrates a support level at 33.25, which if violated will result in even more drops to 32.81. On the upside, there is a resistance level at 34.32. A further resistance level may holdings at 34.95. The Relative Strength Index (RSI) on the 14-day chart is 63.99, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.51, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 18.13%. Stochastics%K at 86.07% indicates the stock is a selling.

The most recent change occurred on October 24, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $50 price target.

Most Popular